| 2025-12-18 |
详情>>
内部人交易：
Balaguer Susan M.股份减少4976.00股
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本10648.86万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.74美元,归母净利润1.86亿美元,同比去年增长449.50%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘前发布财报
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益1.14美元,归母净利润1.21亿美元,同比去年增长418.03%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益0.62美元,归母净利润6620.30万美元,同比去年增长161.67%
|
| 2025-03-05 |
股东大会：
将于2025-04-15召开股东大会
会议内容 ▼▲
- 1.The election of four director nominees named in the proxy statement;
2.The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2025;
3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;
4.The transaction of any business that may be properly brought before the annual meeting.
|
| 2025-02-19 |
详情>>
业绩披露：
2024年年报每股收益2.21美元,归母净利润2.35亿美元,同比去年增长45.86%
|
| 2025-02-19 |
详情>>
业绩披露：
2022年年报每股收益0.93美元,归母净利润9666.40万美元,同比去年增长50.87%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.32美元,归母净利润3376.80万美元,同比去年增长-70.95%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益-0.36美元,归母净利润-3818.3万美元,同比去年增长-155.5%
|
| 2024-07-31 |
详情>>
业绩披露：
2023年中报每股收益0.66美元,归母净利润6879.40万美元,同比去年增长76.57%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益-1.01美元,归母净利润-1.07亿美元,同比去年增长-520.13%
|
| 2024-03-05 |
股东大会：
将于2024-04-16召开股东大会
会议内容 ▼▲
- 1.The election of four director nominees named in the proxy statement;
2.The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2024;
3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;
4.The transaction of any business that may be properly brought before the annual meeting.
|
| 2024-02-14 |
详情>>
业绩披露：
2023年年报每股收益1.53美元,归母净利润1.61亿美元,同比去年增长66.71%
|
| 2023-11-01 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.11美元,归母净利润1.16亿美元,同比去年增长69.61%
|
| 2023-03-06 |
股东大会：
将于2023-04-18召开股东大会
会议内容 ▼▲
- 1.The election of three director nominees named in the proxy statement;
2.The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2023;
3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;
4.The transaction of any business that may be properly brought before the annual meeting.
|
| 2022-03-02 |
股东大会：
将于2022-04-14召开股东大会
会议内容 ▼▲
- 1.The election of two director nominees named in the proxy statement;
2.The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2022;
3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;
4.The transaction of any business that may be properly brought before the annual meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-10 |
股东大会：
将于2021-04-20召开股东大会
会议内容 ▼▲
- 1.The election of four director nominees named in the proxy statement;
2.The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2021;
3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;
4.The transaction of any business that may be properly brought before the annual meeting.
|
| 2020-03-10 |
股东大会：
将于2020-04-21召开股东大会
会议内容 ▼▲
- 1.The election of three director nominees named in the proxy statement;
2.The ratification of the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2020;
3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement
4.A non-binding, advisory vote on the frequency of future advisory votes to approve named executive compensation;
5.The approval of the Employee Stock Purchase Plan;
6.The transaction of any other business that may properly be brought before the annual meeting.
|